Antidiabetic tricyclic compounds

Novel compounds of the structural formula (I), and the pharmaceutically acceptable salts thereof, are agonists of G-protein coupled receptor 40 (GPR40) and may be useful in the treatment, prevention and suppression of diseases mediated by the G-protein-coupled receptor 40. The compounds of the prese...

Ausführliche Beschreibung

Bibliographische Detailangaben

Hauptverfasser:	BLIZZARD TIMOTHY A, HAGMANN WILLIAM K, NAIR ANILKUMAR G, FRIE JESSICA L, CHEN ZHENGXIA, BIFU TESFAYE, JOSIEN HUBERT, ZHU CHENG, CUI MINGXIANG, BIJU PURAKKATTLE, PLUMMER CHRISTOPHER W, CLEMENTS MATTHEW J, HU BIN
Format:	Patent
Sprache:	chi ; eng
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!